Iveta Selingerová

531 total citations
63 papers, 353 citations indexed

About

Iveta Selingerová is a scholar working on Oncology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Iveta Selingerová has authored 63 papers receiving a total of 353 indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Oncology, 19 papers in Cancer Research and 15 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Iveta Selingerová's work include Breast Cancer Treatment Studies (10 papers), Glioma Diagnosis and Treatment (8 papers) and Cancer Immunotherapy and Biomarkers (8 papers). Iveta Selingerová is often cited by papers focused on Breast Cancer Treatment Studies (10 papers), Glioma Diagnosis and Treatment (8 papers) and Cancer Immunotherapy and Biomarkers (8 papers). Iveta Selingerová collaborates with scholars based in Czechia, United States and Poland. Iveta Selingerová's co-authors include Tomáš Kazda, Pavel Šlampa, M Slavík, Alexandr Poprach, Petr Pospíšil, Lenka Zdražilová Dubská, Ondřej Slabý, Jiří Šáňa, Michal Hendrych and Dalibor Valík and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Scientific Reports.

In The Last Decade

Iveta Selingerová

51 papers receiving 347 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Iveta Selingerová Czechia 11 130 88 86 71 69 63 353
Dayang Hui China 8 116 0.9× 45 0.5× 67 0.8× 51 0.7× 47 0.7× 13 285
Brian Khong United States 7 121 0.9× 84 1.0× 96 1.1× 44 0.6× 34 0.5× 12 374
Dong Wu China 14 89 0.7× 80 0.9× 67 0.8× 227 3.2× 63 0.9× 39 545
Hong Cen China 8 128 1.0× 45 0.5× 94 1.1× 91 1.3× 72 1.0× 16 348
Boju Pan China 10 188 1.4× 55 0.6× 34 0.4× 133 1.9× 84 1.2× 33 421
Amy Joehlin‐Price United States 11 174 1.3× 62 0.7× 62 0.7× 71 1.0× 48 0.7× 30 418
Jens Ole Eriksen Denmark 14 189 1.5× 199 2.3× 88 1.0× 132 1.9× 172 2.5× 40 623
Laura Mansi France 12 228 1.8× 80 0.9× 94 1.1× 85 1.2× 57 0.8× 30 373
Nai‐Kong V. Cheung United States 8 145 1.1× 83 0.9× 65 0.8× 164 2.3× 60 0.9× 9 411

Countries citing papers authored by Iveta Selingerová

Since Specialization
Citations

This map shows the geographic impact of Iveta Selingerová's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Iveta Selingerová with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Iveta Selingerová more than expected).

Fields of papers citing papers by Iveta Selingerová

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Iveta Selingerová. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Iveta Selingerová. The network helps show where Iveta Selingerová may publish in the future.

Co-authorship network of co-authors of Iveta Selingerová

This figure shows the co-authorship network connecting the top 25 collaborators of Iveta Selingerová. A scholar is included among the top collaborators of Iveta Selingerová based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Iveta Selingerová. Iveta Selingerová is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Püsküllüoğlu, Mirosława, Anna Polakiewicz-Gilowska, Iveta Selingerová, et al.. (2025). 566P Effectiveness of sacituzumab govitecan in patients with metastatic triple-negative breast cancer: A real-world retrospective cohort study from central Europe. Annals of Oncology. 36. S419–S419.
2.
Burkoň, Petr, Iveta Selingerová, Oldřich Coufal, et al.. (2025). Quality of life in early breast cancer patients after adjuvant accelerated partial-breast irradiation (APBI) in randomized trial. Scientific Reports. 15(1). 1387–1387.
3.
Selingerová, Iveta, et al.. (2024). Treatment and Prognosis of Male Breast Cancer: A Multicentric, Retrospective Study Over 11 Years in the Czech Republic. The Oncologist. 29(6). e750–e762. 5 indexed citations
4.
Selingerová, Iveta, Radek Lakomý, Alexandr Poprach, et al.. (2024). Early changes of peripheral circulating immune subsets induced by PD-1 inhibitors in patients with advanced malignant melanoma and non-small cell lung cancer. BMC Cancer. 24(1). 1590–1590. 1 indexed citations
5.
6.
Burkoň, Petr, Iveta Selingerová, M Slavík, et al.. (2024). Toxicity of external beam accelerated partial-breast irradiation (APBI) in adjuvant therapy of early-stage breast cancer: prospective randomized study. Radiation Oncology. 19(1). 17–17. 2 indexed citations
7.
Selingerová, Iveta, Petr Pospíšil, Martin Bulik, et al.. (2024). Hippocampal subfield volumetric changes after radiotherapy for brain metastases. Neuro-Oncology Advances. 6(1). vdae040–vdae040. 2 indexed citations
8.
Lakomý, Radek, Regina Demlová, Alexandr Poprach, et al.. (2024). 11C-methionine in the diagnostics and management of glioblastoma patients with rapid early progression: nonrandomized, open label, prospective clinical trial (GlioMET). BMC Cancer. 24(1). 736–736. 3 indexed citations
9.
10.
11.
Selingerová, Iveta, et al.. (2023). Comparison of 3 Different Systems for Non-wire Localization of Lesions in Breast Cancer Surgery. Clinical Breast Cancer. 23(6). e323–e330. 5 indexed citations
12.
Selingerová, Iveta, et al.. (2022). Sunitinib-Induced Elevation of Mean Corpuscular Volume (MCV)—Exploring Its Possible Clinical Relevance in Cancer Patients. Current Oncology. 29(6). 4138–4147. 2 indexed citations
13.
Slavík, M, et al.. (2020). The tumor immune microenvironment and its implications for clinical outcome in patients with oropharyngeal squamous cell carcinoma. Journal of Oral Pathology and Medicine. 49(9). 886–896. 15 indexed citations
14.
Musilová, Petra, et al.. (2020). Different chromosome damage in lymphocytes of newly diagnosed gastrointestinal and breast cancer patients. Neoplasma. 67(3). 668–676. 1 indexed citations
15.
Selingerová, Iveta, Zdeněk Řehák, Dalibor Valík, et al.. (2019). Assessment of Immune Response Following Dendritic Cell-Based Immunotherapy in Pediatric Patients With Relapsing Sarcoma. Frontiers in Oncology. 9. 1169–1169. 13 indexed citations
16.
17.
18.
Sommerová, Lucia, Pavla Bouchalová, Eva Jandáková, et al.. (2019). The role of miR-409-3p in regulation of HPV16/18-E6 mRNA in human cervical high-grade squamous intraepithelial lesions. Antiviral Research. 163. 185–192. 17 indexed citations
19.
Slavík, M, Markéta Hermanová, Jiří Šáňa, et al.. (2018). Prognostic impact of combined immunoprofiles in oropharyngeal squamous cell carcinoma patients with respect to AJCC 8th edition. Journal of Oral Pathology and Medicine. 47(9). 864–872. 5 indexed citations
20.
Burkoň, Petr, Tomáš Kazda, Petr Pospíšil, et al.. (2018). Ablative dose stereotactic body radiation therapy for oligometastatic disease: a prospective single institution study. Neoplasma. 66(2). 315–325. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Dayang Hui Breakdown of academic impact, for papers by Brian Khong Breakdown of academic impact, for papers by Dong Wu Breakdown of academic impact, for papers by Hong Cen Breakdown of academic impact, for papers by Boju Pan Breakdown of academic impact, for papers by Amy Joehlin‐Price Breakdown of academic impact, for papers by Jens Ole Eriksen Breakdown of academic impact, for papers by Laura Mansi Breakdown of academic impact, for papers by Nai‐Kong V. Cheung
Rankless by CCL
2026